Clinical Trials Logo

Spasm clinical trials

View clinical trials related to Spasm.

Filter by:

NCT ID: NCT03876444 Recruiting - Infantile Spasm Clinical Trials

Intravenous Methylprednisolone Versus Oral Prednisolone for Infantile Spasms

MPIV
Start date: April 1, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

Infantile Spasms (IS) are classically refractory to the usual antiepileptic drugs and often pose a therapeutic challenge. Since, there is associated significant morbidity, much effort has been directed over the past years to evaluate the role of various anticonvulsants in the management of IS. High dose oral prednisolone has been shown to cause early cessation of spasms and resolution of hypsarrythmia on Electroencephalogram. Recently, role of intravenous methylprednislone pulse therapy has been explored as one of the therapeutic modality in IS, in order to avoid the development of side-effects associated with prolonged oral steroid therapy and maintain long-term efficacy.However, there are no studies comparing iv methylprednisolone pulse therapy with high dose oral prednisolone..

NCT ID: NCT03864770 Recruiting - Clinical trials for Nocturnal Leg Cramps

Extracorporeal Shock Wave Therapy Treatment for Nocturnal Leg Cramps

Start date: March 5, 2019
Phase: N/A
Study type: Interventional

Nocturnal leg cramps (NLCs) are often described as a symptom of sudden and involuntary muscle contraction at night, which often affects sleep quality due to pain and tight discomfort in the thigh, calf and foot. The investigator performed extracorporeal shock wave therapy (ESWT). This experiment used a randomized experiment to assess the immediate, short-term and long-term effects of extracorporeal shock wave therapy on patients with nocturnal leg cramps.

NCT ID: NCT03807141 Recruiting - Epileptic Spasms Clinical Trials

Evaluation of the Modified Atkins Diet in Children With Epileptic Spasms

Start date: January 15, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

Epileptic spasms are a difficult to treat epileptic condition in young children. The first line treatment is hormonal treatment, in the form of ACTH or oral steroids, which are effective in 60-70% of children. The condition does not respond well to other anti-epileptic drugs except vigabatrin which is not approved and hence has limited availability and high cost in India. The ketogenic diet, a high fat low carbohydrate diet has been found to be effective in refractory childhood epilepsy especially epileptic spasms. However, the ketogenic diet restricts calories and proteins and required strict weighing of foods. The modified Atkins diet (MAD) is a less restrictive diet which is easier for the parents to prepare and for the children to consume. In this study, it is planned to evaluate the efficacy of the MAD in children with epileptic spasms refractory to hormonal treatment in a randomized controlled trial.

NCT ID: NCT03660969 Recruiting - Muscle Weakness Clinical Trials

Reliability of Cardiac Troponins for the Diagnosis of Myocardial Infarction in the Presence of Skeletal Muscle Disease

H&M
Start date: January 1, 2018
Phase:
Study type: Observational

Visits to the emergency department (ED) for chest pain are extremely common and require a safe, rapid and efficacious treatment algorithm to exclude a possible AMI. These diagnostic algorithms are partly based on an important laboratory value, which showed growing utility in the diagnostic and prognostic of many cardiovascular diseases in the last years : cardiac troponin. However, some patients with muscle disease often present with unexplained elevated high-sensitive cardiac Troponin T (hs-cTnT) levels in the absence of cardiac disease. The investigators aim at the characterization of the behaviour of this biomarker and its alternative (high-sensitive cardiac Troponin I), which will have important clinical implications on patients management.

NCT ID: NCT03570671 Recruiting - Spasm Clinical Trials

Noninvasive Cardiac Imaging in Vasospastic Angina Korean Registry (NAVIGATOR)

NAVIGATOR
Start date: March 1, 2018
Phase: N/A
Study type: Interventional

With regard to the characteristics of spasm segment, had been clearly described by other invasive imaging methods including intravascular ultrasound and optical coherence tomography. However, there is potential risk during these invasive procedures, such as severe myocardial ischemia or fatal arrhythmia. Presently available imaging test for coronary artery disease in multi detector-row computed tomography angiography (MDCTA) evaluation has high diagnostic accuracy to evaluate coronary artery stenosis. However, previous report assessing imaging findings or diagnostic accuracy of MDCTA in patients with vasospastic angina (VSA) is lacking.

NCT ID: NCT03501212 Recruiting - Radial Artery Spasm Clinical Trials

Effect of Topical Anesthesia on Patient's Pain Discomfort and Radial Artery Spasm in Transradial Catheterization

Start date: April 27, 2019
Phase: Phase 4
Study type: Interventional

This study evaluate topical anaesthesia application for 30 minutes before tranradial catheterization during cardiac catheterization can reduce pain and decrease radial artery spasm

NCT ID: NCT03306940 Recruiting - Hemifacial Spasm Clinical Trials

Botulinum Toxin A in the Treatment of Hemifacial Spasm

BTATHS
Start date: October 2, 2017
Phase: N/A
Study type: Interventional

Hemifacial spasm patients who received botulinum toxin A injection were divided into two groups. Group A received unilateral injection while group B received bilateral injection. Patients completed follow-up A researcher record facial videos and analyzed facial symmetry and completed 3 scales.

NCT ID: NCT03085745 Recruiting - Writer's Cramp Clinical Trials

Sensorimotor Mapping in Patients With Writer's Cramp

IWCToxin
Start date: February 20, 2017
Phase: N/A
Study type: Interventional

Writer's cramp (WC) is a form of focal dystonia, a movement disorder characterized by sustained or intermittent muscle contractions causing abnormal, often repetitive movements, postures, or both. It typically manifests while writing, making handwriting impossible in the most severe cases. Treatment can be difficult, but one effective and well-tolerated treatment consists in local muscle injections with botulinum toxin. Although clinical improvement seems to be related to focal muscle chemodenervation, central plasticity changes may occur. The main aim of the study is to characterize and quantify the changes in intrinsic hand muscle cortical representations at rest and during isometric contractions of the finger muscles before and after treatment with botulinum toxin and the changes in sensorimotor integration in patients with writer's cramp.

NCT ID: NCT02642874 Recruiting - Liver Cirrhosis Clinical Trials

Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients

Start date: April 1, 2017
Phase: Phase 3
Study type: Interventional

Muscle cramps markedly affect the quality of life in cirrhotic patients with no highly effective drug. Methocarbamol is a central muscle relaxant used to treat skeletal muscle spasms. The mechanism of action of methocarbamol is currently unknown, but may involve the inhibition of carbonic anhydrase. Methocarbamol has a high therapeutic index, i.e. a wide range of safe and effective dosages.

NCT ID: NCT02423395 Recruiting - Liver Cirrhosis Clinical Trials

Study of Orphenadrine` in the Treatment of Muscle Cramps in Patients With Cirrhosis

Start date: January 2015
Phase: Phase 3
Study type: Interventional

Muscle cramps are common in patients with liver disease and associated with significantly diminished quality of life. Patients with cirrhosis often experience muscle cramps with varied frequency and severity. The exact mechanisms by which they occur remain unclear, although a number of pathophysiological events unique to liver disease may contribute. Clinical studies have identified alterations in 3 areas: nerve function, energy metabolism, and plasma volume/electrolytes (1) Orphenadrine is an anticholinergic drug with prominent central nervous system (CNS) and peripheral actions used to treat painful muscle spasms and other similar conditions. The combination of anticholinergic effects and CNS penetration make orphenadrine useful for pain of all etiologies, including from: radiculopathy, muscles, and headaches. [3,4]